Beximco Pharmaceuticals Ltd. GDR Stock
There is an upward development for Beximco Pharmaceuticals Ltd. GDR compared to yesterday, with an increase of €0.006 (1.360%).
Pros and Cons of Beximco Pharmaceuticals Ltd. GDR in the next few years
Pros
?
S********** s********
?
B****
?
C******** o* t** e**********
Cons
?
M***** P*******
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Beximco Pharmaceuticals Ltd. GDR vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Beximco Pharmaceuticals Ltd. GDR | 1.360% | -1.778% | -1.778% | 6.250% | 6.250% | -25.714% | -58.692% |
| SELLAS Life Sciences Group Inc | -3.170% | 20.896% | 103.664% | 201.275% | 201.275% | 33.349% | -44.127% |
| Eledon Pharmaceuticals Inc. | -6.570% | 1.481% | 5.385% | -66.422% | -66.422% | -35.377% | -88.770% |
| Check Cap Ltd | - | -5.369% | 2.174% | 35.577% | 35.577% | -26.124% | 418.382% |
News
Why Atai Life Sciences Stock Was So Lively This Week
Atai Life Sciences (NASDAQ: ATAI), a biotech focused on developing psychedelic-based medicines to treat mental health disorders, was a standout stock over the past few days in its rather limited
Why Atai Life Sciences Stock Crushed It on Tuesday
Atai Life Sciences (NASDAQ: ATAI), an ambitious biotech that targets mental health disorders, was a hot item among equity investors Tuesday. The company saw its share price rise by just under 15%